Highlights from the 2004-2005 Performance assessment report
Improving health outcomes
The number of people receiving antiretroviral treatment in low- and middle-income countries increased — from 400 000 in December 2003 to more than 1.3 million in December 2005. WHO remains committed to achieving universal access.
In 2005, a new strategy to stop tuberculosis (Stop TB), built around DOTS, was formulated and the Stop TB Partnership's global Drug Facility delivered more than 2.4 million patient treatments to 65 countries.
The number of countries endemic for dracunculiasis was reduced from 13 in 2003 to nine in 2005.
A memorandum of understanding was signed with a manufacturer guaranteeing free supply of multi-drug therapy for leprosy worldwide up to the end of 2010.